dacarbazine has been researched along with Colorectal Neoplasms, Hereditary Nonpolyposis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantelli, E; De Vries, S; Dekker, M; Delzenne-Goette, E; Plug, M; Song, JY; Te Riele, H; Van Der Wal, A; Van Gerwen, B; Wojciechowicz, K | 1 |
Bartosova, Z; Bonmassar, L; Cattaruzza, MS; Corti, C; D'Atri, S; Heinimann, K; Jiricny, J; Marra, G; Nyström-Lahti, M; Schweizer, P | 1 |
2 other study(ies) available for dacarbazine and Colorectal Neoplasms, Hereditary Nonpolyposis
Article | Year |
---|---|
Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Topics: Adenocarcinoma; Adenoma; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Colorectal Neoplasms, Hereditary Nonpolyposis; Dacarbazine; Disease Models, Animal; DNA Mismatch Repair; Female; Intestinal Mucosa; Intestines; Male; Mice, Knockout; MutS Homolog 2 Protein; Neoplastic Stem Cells; Risk Factors; Temozolomide; Time Factors | 2014 |
Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Alkylating; Carrier Proteins; Cell Line; Cell Survival; Colorectal Neoplasms, Hereditary Nonpolyposis; Dacarbazine; DNA Repair; DNA-Binding Proteins; Heterozygote; Humans; Lymphocytes; Mutation; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Proto-Oncogene Proteins; Temozolomide; Tumor Cells, Cultured | 2001 |